IL125534A - Unit dose of budesonide and use thereof for nasal administration - Google Patents

Unit dose of budesonide and use thereof for nasal administration

Info

Publication number
IL125534A
IL125534A IL12553497A IL12553497A IL125534A IL 125534 A IL125534 A IL 125534A IL 12553497 A IL12553497 A IL 12553497A IL 12553497 A IL12553497 A IL 12553497A IL 125534 A IL125534 A IL 125534A
Authority
IL
Israel
Prior art keywords
budesonide
unit dose
nasal administration
mug
nose
Prior art date
Application number
IL12553497A
Other languages
English (en)
Other versions
IL125534A0 (en
Inventor
Hans Nilsson
Gordon Santesson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26662810&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL125534(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9604486A external-priority patent/SE9604486D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL125534A0 publication Critical patent/IL125534A0/xx
Publication of IL125534A publication Critical patent/IL125534A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IL12553497A 1996-12-05 1997-11-28 Unit dose of budesonide and use thereof for nasal administration IL125534A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9604486A SE9604486D0 (sv) 1996-12-05 1996-12-05 Novel formulation
US08/846,960 US6291445B1 (en) 1996-12-05 1997-04-29 Low dose budesonide formulations and uses thereof
PCT/SE1997/001998 WO1998024450A1 (en) 1996-12-05 1997-11-28 Novel formulation

Publications (2)

Publication Number Publication Date
IL125534A0 IL125534A0 (en) 1999-04-11
IL125534A true IL125534A (en) 2003-06-24

Family

ID=26662810

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12553497A IL125534A (en) 1996-12-05 1997-11-28 Unit dose of budesonide and use thereof for nasal administration

Country Status (23)

Country Link
US (2) US6686346B2 (hu)
EP (1) EP0907365B1 (hu)
JP (1) JP2000508675A (hu)
CN (1) CN1168450C (hu)
AT (2) ATE369118T1 (hu)
AU (1) AU726515B2 (hu)
BE (1) BE1011394A5 (hu)
CZ (1) CZ295792B6 (hu)
DE (2) DE69738000T2 (hu)
DK (1) DK0907365T3 (hu)
ES (1) ES2133130B1 (hu)
FR (1) FR2756739B1 (hu)
GR (1) GR1003011B (hu)
HK (1) HK1020522A1 (hu)
HU (1) HUP0000575A3 (hu)
IE (1) IE970854A1 (hu)
IL (1) IL125534A (hu)
NL (1) NL1007706C2 (hu)
NO (1) NO983555L (hu)
NZ (1) NZ330925A (hu)
PT (1) PT907365E (hu)
TR (1) TR199801501T1 (hu)
WO (1) WO1998024450A1 (hu)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AU2002337692B2 (en) 2001-09-26 2007-09-13 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
WO2005027853A2 (en) * 2003-09-19 2005-03-31 University Of Louisville Research Foundation Inc Method for treating snoring and sleep apnea with leukotriene antagonists
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
JP2011503113A (ja) 2007-11-13 2011-01-27 メリテイジ ファーマ，インク． 胃腸炎の治療用組成物
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
RU2513142C2 (ru) 2008-06-12 2014-04-20 Медтроник Ксомед Инк. Способ лечения хронических ран
WO2010042427A2 (en) 2008-10-06 2010-04-15 Microbial Defense Systems, Llc Antimicrobial composition and methods of making and using same
WO2010144865A2 (en) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
CN112516087B (zh) * 2020-12-24 2023-03-24 四川普锐特药业有限公司 布地奈德鼻喷剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (hu) * 1972-05-19 1975-08-18 Bofors Ab
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
SK282826B6 (sk) * 1991-12-18 2002-12-03 Aktiebolaget Astra Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
US5509404A (en) 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
WO1997001341A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
JPH11511758A (ja) * 1996-06-04 1999-10-12 ザ、プロクター、エンド、ギャンブル、カンパニー 鼻腔用ステロイドと抗ヒスタミン剤を含む鼻腔内噴霧薬
SE9604486D0 (sv) * 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide

Also Published As

Publication number Publication date
JP2000508675A (ja) 2000-07-11
PT907365E (pt) 2003-09-30
HK1020522A1 (en) 2000-05-12
NL1007706C2 (nl) 1998-09-22
GR1003011B (el) 1998-11-20
HUP0000575A3 (en) 2001-03-28
HUP0000575A2 (hu) 2000-10-28
ATE239482T1 (de) 2003-05-15
CN1168450C (zh) 2004-09-29
FR2756739A1 (fr) 1998-06-12
US6686346B2 (en) 2004-02-03
DE69721766T2 (de) 2004-03-04
ES2133130A1 (es) 1999-08-16
DE69721766D1 (de) 2003-06-12
ES2133130B1 (es) 2000-03-01
CN1210467A (zh) 1999-03-10
DE69738000T2 (de) 2008-04-17
NO983555D0 (no) 1998-08-03
DE69738000D1 (de) 2007-09-20
TR199801501T1 (xx) 1999-02-22
NO983555L (no) 1998-08-03
EP0907365B1 (en) 2003-05-07
CZ295792B6 (cs) 2005-11-16
EP0907365A1 (en) 1999-04-14
NL1007706A1 (nl) 1998-06-08
AU726515B2 (en) 2000-11-09
US20040101486A1 (en) 2004-05-27
AU5421198A (en) 1998-06-29
FR2756739B1 (fr) 2000-04-28
ATE369118T1 (de) 2007-08-15
DK0907365T3 (da) 2003-08-04
BE1011394A5 (fr) 1999-08-03
IE970854A1 (en) 1998-10-07
US20020016315A1 (en) 2002-02-07
GR970100477A (el) 1998-08-31
IL125534A0 (en) 1999-04-11
CZ243798A3 (cs) 1998-11-11
NZ330925A (en) 2000-05-26
WO1998024450A1 (en) 1998-06-11
US6986904B2 (en) 2006-01-17

Similar Documents

Publication Publication Date Title
IL125534A0 (en) A unit dose of budesonide and use thereof for nasal administration
SE9604486D0 (sv) Novel formulation
GEP20043260B (en) Aerosolized Active Agent Delivery and Device for Realization Thereof
MX9605650A (es) Formulaciones de propionato de fluticasona.
GEP20002266B (en) Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
WO1994027589A3 (en) Antidepressant dosage form
OA09868A (en) Non-chorofluorocarbon aerosol formulation.
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
GB2365772A (en) Factor
GEP20002254B (en) Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
GR3021424T3 (en) Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity
GB9918559D0 (en) Novel pharmaceutical formulation
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
IL120558A0 (en) New hormonal medicaments and their use for the correction of oestrogenic deficiencies
HUT60438A (en) Application of inhaled non-steroid inflammation reducers for potentiation of antireactive, antiasthmatic effect of inhaled henle's loop-diuretics
GB9806462D0 (en) Improved compositions for inhalation
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
EP1101493A3 (en) New combination of formoterol and budesonide
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
TW360538B (en) Pharmaceutical composition containing 4'-iodo-4'-deoxydoxorubicin for treatment of amyloidosis

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXTP Application for extension order is pending
EXTN Extension order renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
MM9K Patent not in force due to non-payment of renewal fees